Proteomics. Clinical Applications, 1862-8346

Journal

  1. 2019
  2. Hoff, F. W., Hu, C. W., Qutub, A. A., Qiu, Y., Hornbaker, M. J., Bueso-Ramos, C., Abbas, H. A., Post, S. M., de Bont, E. S. J. M., & Kornblau, S. M. (2019). Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse. Proteomics. Clinical Applications, 13(4), [1800133]. https://doi.org/10.1002/prca.201800133
  3. Zeneyedpour, L., Dekker, L. J. M., van Sten-van't Hoff, J. J. M., Burgers, P. C., ten Hacken, N. H. T., & Luider, T. M. (2019). Neoantigens in Chronic Obstructive Pulmonary Disease and Lung Cancer: A Point of View. Proteomics. Clinical Applications, 13(2), [1800093]. https://doi.org/10.1002/prca.201800093
  4. 2018
  5. 2014
  6. Ljunggren, S., Levels, J. H. M., Turkina, M. V., Sundberg, S., Bochem, A. E., Hovingh, K., Holleboom, A. G., Lindahl, M., Kuivenhoven, J. A., & Karlsson, H. (2014). ApoA-I mutations, L202P and K131del, in HDL from heterozygotes with low HDL-C. Proteomics. Clinical Applications, 8(3-4), 241-250. https://doi.org/10.1002/prca.201300014
  7. 2007

ID: 13948966